Bixiye
QP6-18 Updated Commercial PA Request Form and PA List for Early Intensive Behavioral Intervention Services
Taariikhda uu dhaqangalayo Barnaamijka: Jan 17, 2018
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 3031 - 3040 ee natiijooyinka 3289
Bixiye
QP5-18 Quality Initiatives at Blue Cross
Taariikhda uu dhaqangalayo Barnaamijka: Jan 16, 2018
Bixiye
QP4-18 Remember to Request Subscriber ID Cards
Taariikhda uu dhaqangalayo Barnaamijka: Jan 16, 2018
Bixiye
P2-18 New Medical Drug PA Requirements for Voretigene Neparvovec (Luxturna)
Taariikhda uu dhaqangalayo Barnaamijka: Jan 11, 2018
Bixiye
P1-18 New Drugs, Aimovig (erenumab), Fremanezumab and Galcanezumab Will Require PA
Taariikhda uu dhaqangalayo Barnaamijka: Jan 09, 2018
Bixiye
QP3-18 Pharmacy Benefit Update - Helixate FS Will No Longer Be Covered
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2018
Bixiye
QP2-18 Pharmacy Benefit Exclusion for Luxturna
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2018
Bixiye
QP1-18 Transition of Care Management Features for New Medicare Advantage Prescription Drug Plans
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2018
Bixiye
2017 December Provider Press
Taariikhda uu dhaqangalayo Barnaamijka: Des 29, 2017
Bixiye
P83-17 Clarification to MHCP Prior Authorization Requirements for Nusinersen (Spinraza)
Taariikhda uu dhaqangalayo Barnaamijka: Des 13, 2017